-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Empower Clinics Announces New Auditor and Change of Year End
Empower Clinics Announces New Auditor and Change of Year End
VANCOUVER, BC / ACCESSWIRE / December 23, 2022 / EMPOWER CLINICS INC (CSE:EPW)(OTC PINK:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, a medical device company and a high complexity medical diagnostics laboratory is pleased to announce the appointment of Zeifmans LLP ("Zeifmans") as its new auditor effective December 20, 2022, and announces the change of its year end to March 31st.
Zeifmans replaces MNP LLP ("MNP") as Empower's auditor. The board of directors (the "Board") and management of Empower would like to thank MNP for their services. The change in auditor has been approved by the Company's audit committee and the Board.
There was no modified opinion expressed in Zeifmans' report on any of the Company's financial statements relating to the period commencing at the beginning of the Company's two most recently completed financial years and ending on the date of resignation of MNP. There have been no "reportable events" within the meaning assigned under subsection 4.11(1) of National Instrument 51‐102 Continuous Disclosure Obligations.
The Company today also announces the change of its year end from December 31 to March 31.
"These are important milestones for our Company, that are intended to ensure we improve our accounting, audit and financial controls going forward," stated Steven McAuley, Chairman & CEO. "Zeifmans have decades of technical accounting and audit experience, and came with tremendous trade references from other issuers in Canada."
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions, and engagement with management
ABOUT EMPOWER:
Empower is an integrated healthcare company with multi-disciplinary clinics, an at-home medical testing device company and state-of-the-art medical diagnostics laboratories. With a growing presence in the U.S. and Canada. Empower is a leader in integrated healthcare and diagnostics solutions and is reshaping the model for patient-first wellness.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Media:
Steven McAuley CEO
s.mcauley@empowerclinics.com
+1 855-855-9058
Investors:
Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
+1 855-855-9058
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Such forward-looking statements are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements. No assurance can be given that any of the events anticipated by the forward-looking statements will occur on the terms or in the time expected, or at all, or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.
SOURCE: Empower Clinics Inc.
View source version on accesswire.com:
VANCOUVER, BC / ACCESSWIRE / December 23, 2022 / EMPOWER CLINICS INC (CSE:EPW)(OTC PINK:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, a medical device company and a high complexity medical diagnostics laboratory is pleased to announce the appointment of Zeifmans LLP ("Zeifmans") as its new auditor effective December 20, 2022, and announces the change of its year end to March 31st.
温哥华,BC/ACCESSWIRE/2022年12月23日/Empower Clinics Inc.(CSE:EPW)(场外PINK:EPWCF)("增强能力“或”公司)一家通过医疗中心、一家医疗器械公司和一家高复杂性医疗诊断实验室为患者提供服务的综合医疗保健公司高兴地宣布任命Zeifman LLP(泽伊夫曼“)为其新的审计师,自2022年12月20日起生效,并宣布将其年终改为3月31日。
Zeifmans replaces MNP LLP ("MNP") as Empower's auditor. The board of directors (the "Board") and management of Empower would like to thank MNP for their services. The change in auditor has been approved by the Company's audit committee and the Board.
蔡夫曼取代了MNP LLP(“MNP“)作为授权的审计师。董事会(The”冲浪板“)和Empower的管理层感谢MNP的服务。更换审计师的决定已得到公司审计委员会和董事会的批准。
There was no modified opinion expressed in Zeifmans' report on any of the Company's financial statements relating to the period commencing at the beginning of the Company's two most recently completed financial years and ending on the date of resignation of MNP. There have been no "reportable events" within the meaning assigned under subsection 4.11(1) of National Instrument 51‐102 Continuous Disclosure Obligations.
泽伊曼斯公司的报告中没有对公司最近两个财政年度开始至MNP辞职之日止期间的任何财务报表发表任何修改意见。在《国家文书51-102连续披露义务》第4.11(1)节中所指定的含义内,并未出现“需要报告的事件”。
The Company today also announces the change of its year end from December 31 to March 31.
该公司今天还宣布将其年终日期从12月31日改为3月31日。
"These are important milestones for our Company, that are intended to ensure we improve our accounting, audit and financial controls going forward," stated Steven McAuley, Chairman & CEO. "Zeifmans have decades of technical accounting and audit experience, and came with tremendous trade references from other issuers in Canada."
董事长兼首席执行官史蒂文·麦考利说:“这些都是我们公司的重要里程碑,旨在确保我们今后改进我们的会计、审计和财务控制。Zeifman拥有数十年的技术会计和审计经验,并从加拿大其他发行人那里获得了大量的贸易参考资料。
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions, and engagement with management
本新闻稿可在AGORACOM上的授权诊所验证论坛上获取,以供股东讨论、提问和与管理层接触
ABOUT EMPOWER:
关于授权:
Empower is an integrated healthcare company with multi-disciplinary clinics, an at-home medical testing device company and state-of-the-art medical diagnostics laboratories. With a growing presence in the U.S. and Canada. Empower is a leader in integrated healthcare and diagnostics solutions and is reshaping the model for patient-first wellness.
Empower是一家综合性医疗保健公司,拥有多学科诊所、家用医疗检测设备公司和最先进的医疗诊断实验室。在美国和加拿大的影响力越来越大。Empower是集成医疗保健和诊断解决方案的领先者,正在重塑患者至上的健康模式。
ON BEHALF OF THE BOARD OF DIRECTORS:
我谨代表董事会:
Steven McAuley
Chief Executive Officer
史蒂文·麦考利
首席执行官
CONTACTS:
联系人:
Media:
媒体:
Steven McAuley CEO
s.mcauley@empowerclinics.com
+1 855-855-9058
史蒂文·麦考利首席执行官
邮箱:s.mcauley@empower Clinics.com
+1 855-855-9058
Investors:
投资者:
Tamara Mason
塔玛拉·梅森
Business Development & Communications
t.mason@empowerclinics.com
+1 855-855-9058
业务发展与沟通
邮箱:t.mason@empower Clinics.com
+1 855-855-9058
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
对前瞻性陈述的免责声明
This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Such forward-looking statements are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements. No assurance can be given that any of the events anticipated by the forward-looking statements will occur on the terms or in the time expected, or at all, or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.
本新闻稿包含适用于加拿大证券法的某些“前瞻性陈述”或“前瞻性信息”(统称为“前瞻性陈述”)。除有关历史事实的陈述外,所有陈述均为前瞻性陈述,均基于截至本新闻稿发布之日的预期、估计和预测。前瞻性表述常常可以用“计划”、“继续”、“预期”、“项目”、“打算”、“相信”、“预期”、“估计”、“可能”、“将”、“潜在”、“建议”和其他类似词语,或某些事件或条件“可能”或“将”发生的信息来识别。此类前瞻性陈述是基于管理层目前已知的假设,会受到风险和不确定因素的影响,这些风险和不确定性可能会导致实际结果、业绩或发展与前瞻性陈述中包含的大不相同。不能保证前瞻性陈述中预期的任何事件将按照预期的条款或时间发生,或者根本不能保证,或者如果发生了,公司将从中获得什么好处。告诫读者不要过度依赖本新闻稿中的前瞻性陈述,这些前瞻性陈述完全受这些警告性陈述的限制。除适用的证券法明确要求外,公司没有义务更新或修改本新闻稿中的任何前瞻性陈述,除非适用的证券法明确要求,无论是由于新信息、未来事件还是其他原因。
SOURCE: Empower Clinics Inc.
资料来源:Empower Clinics Inc.
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧